<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, no specific treatment against SARS-CoV-2 has been developed, but research thus far has revealed several agents that may have potential efficacy against COVID-19 (
 <xref rid="T1" ref-type="table">Table 1</xref>). Several broad-spectrum antiviral drugs, already approved for other viral infections, are now being tested to treat COVID-19. Meanwhile, anti-inflammatory drugs are given to prevent ARDS. The use of antiviral therapy should be applied early during the disease, when anti-inflammatory therapy, like corticosteroids, could be harmful and induce viral replication. However, once the disease is advanced and the hyper inflammation is the driver of the disease, the use of anti-inflammatories is suggested, while antiviral therapy could be ineffective (
 <xref rid="B107" ref-type="bibr">107</xref>).
</p>
